Process for preparing pyrrolotriazine kinase inhibitors

Details for Australian Patent Application No. 2004212435 (hide)

Owner Bristol-Myers Squibb Company

Inventors Chen, Bang-Chi; Zhao, Rulin; Sundeen, Joseph Edward; Leftheris, Katerina; Hynes, John; Wrobleski, Stephen T.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004212435

PCT Pub. Number WO2004/072030

Priority 60/445,224 05.02.03 US

Filing date 5 February 2004

Wipo publication date 26 August 2004

International Classifications

C07D 253/08 Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/072030 Priority application(s): WO2004/072030

7 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004212436-Paper release compositions having improved adhesion to paper and polymeric films

2004212421-Heteroaryl substituted pyrolls useful as inhibitors of protein kinases